Parametric Portfolio Associates’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
EC
FLAM
PAI
Parametric Portfolio Associates's PRTA Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Prothena Corp (PRTA) stake by 53% in Q1 2022, selling an estimated $1.88M and leaving 47,032 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2502.
Parametric Portfolio Associates first reported a position in PRTA in Q1 2015 and has held it in 29 quarters since. The position peaked at $8.85M in Q3 2021. 174 funds tracked by Wall St. Rank hold PRTA as of Q1 2022.
- Parametric Portfolio Associates held 47,032 shares of Prothena Corp worth $1.72M as of Q1 2022.
- Parametric Portfolio Associates sold 52,106 Prothena Corp shares in Q1 2022, an estimated $1.88M.
- Prothena Corp made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2502 holding.
- Parametric Portfolio Associates first reported a position in Prothena Corp in Q1 2015 and has held it in 29 quarters since.
- Parametric Portfolio Associates's Prothena Corp position peaked at $8.85M in Q3 2021.
- 174 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.